These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23917038)

  • 1. Analyses of marketplace tacrolimus drug product quality: bioactivity, NMR and LC-MS.
    Sommers CD; Pang ES; Ghasriani H; Berendt RT; Vilker VL; Keire DA; Boyne MT
    J Pharm Biomed Anal; 2013 Nov; 85():108-17. PubMed ID: 23917038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation, synthesis and characterization of tacrolimus impurities.
    Ferraboschi P; Colombo D; De Mieri M; Grisenti P
    J Antibiot (Tokyo); 2012 Jul; 65(7):349-54. PubMed ID: 22511227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of two tacrolimus formulations under fasting conditions in healthy male subjects.
    Mathew P; Mandal J; Patel K; Soni K; Tangudu G; Patel R; Kale P
    Clin Ther; 2011 Sep; 33(9):1105-19. PubMed ID: 21840601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-NMR and LC-MS identification of an impurity in a novel antifungal drug icofungipen.
    Novak P; Tepes P; Ilijas M; Fistrić I; Bratos I; Avdagić A; Hamersak Z; Marković VG; Dumić M
    J Pharm Biomed Anal; 2009 Aug; 50(1):68-72. PubMed ID: 19410412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of process-related impurities and degradation products in larotaxel.
    Che X; Shen L; Xu H; Liu K
    J Pharm Biomed Anal; 2011 Jul; 55(5):1190-6. PubMed ID: 21530132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance and liquid chromatography-mass spectrometry combined with an incompleted separation strategy for identifying the natural products in crude extract.
    Dai D; He J; Sun R; Zhang R; Aisa HA; Abliz Z
    Anal Chim Acta; 2009 Jan; 632(2):221-8. PubMed ID: 19110097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reutilization of Tacrolimus Extracted from Expired Prograf® Capsules: Physical, Chemical, and Pharmacological Assessment.
    Binkhathlan Z; Badran MM; Alomrani A; Aljuffali IA; Alghonaim M; Al-Muhsen S; Halwani R; Alshamsan A
    AAPS PharmSciTech; 2016 Aug; 17(4):978-87. PubMed ID: 26729529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
    Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
    J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
    Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradation pathway of mesotrione: complementarities of NMR, LC-NMR and LC-MS for qualitative and quantitative metabolic profiling.
    Durand S; Sancelme M; Besse-Hoggan P; Combourieu B
    Chemosphere; 2010 Sep; 81(3):372-80. PubMed ID: 20692682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
    Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC
    J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.